TABLE 1. MALE HYPOGONADISM MARKET, BY THERAPY, 2014-2022 ($MILLION)
TABLE 2. TESTOSTERONE REPLACEMENT THERAPY MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 3. GONADOTROPINS AND GONADOTROPINS RELEASING HORMONES THERAPY MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 4. MALE HYPOGONADISM MARKET, BY DRUG DELIVERY, 2014-2022 ($MILLION)
TABLE 5. TOPICAL GEL MARKET FOR MALE HYPOGONADISM, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 6. INJECTABLES MARKET FOR MALE HYPOGONADISM, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 7. TRANSDERMAL PATCHES MARKET FOR MALE HYPOGONADISM, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 8. OTHERS MARKET FOR MALE HYPOGONADISM, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 9. MALE HYPOGONADISM MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 10. MALE HYPOGONADISM MARKET FOR KLINEFELTER'S SYNDROME, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 11. MALE HYPOGONADISM MARKET FOR PITUITARY DISORDERS, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 12. MALE HYPOGONADISM MARKET FOR KALLMANN SYNDROME, BY GEOGRAPHY 2014-2022 ($MILLION)
TABLE 13. MALE HYPOGONADISM MARKET FOR OTHER SYNDROMES, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 14. MALE HYPOGONADISM MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 15. NORTH AMERICA MALE HYPOGONADISM MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 16. NORTH AMERICA MALE HYPOGONADISM MARKET, BY THERAPY, 2014-2022 ($MILLION)
TABLE 17. NORTH AMERICA MALE HYPOGONADISM MARKET, BY DRUG DELIVERY, 2014-2022 ($MILLION)
TABLE 18. NORTH AMERICA MALE HYPOGONADISM MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 19. EUROPE MALE HYPOGONADISM MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 20. EUROPE MALE HYPOGONADISM MARKET, BY THERAPY, 2014-2022 ($MILLION)
TABLE 21. EUROPE MALE HYPOGONADISM MARKET, BY DRUG DELIVERY, 2014-2022 ($MILLION)
TABLE 22. EUROPE MALE HYPOGONADISM MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 23. ASIA-PACIFIC MALE HYPOGONADISM MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 24. ASIA-PACIFIC MALE HYPOGONADISM MARKET, BY THERAPY, 2014-2022 ($MILLION)
TABLE 25. ASIA-PACIFIC MALE HYPOGONADISM MARKET, BY DRUG DELIVERY, 2014-2022 ($MILLION)
TABLE 26. ASIA-PACIFIC MALE HYPOGONADISM MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 27. LAMEA MALE HYPOGONADISM MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 28. LAMEA MALE HYPOGONADISM MARKET, BY THERAPY, 2014-2022 ($MILLION)
TABLE 29. LAMEA MALE HYPOGONADISM MARKET, BY DRUG DELIVERY, 2014-2022 ($MILLION)
TABLE 30. LAMEA MALE HYPOGONADISM MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 31. ABBVIE INC.: COMPANY SNAPSHOT
TABLE 32. ABBVIE INC.: OPERATING SEGMENTS
TABLE 33. ALLERGAN: COMPANY SNAPSHOT
TABLE 34. ALLERGAN: OPERATING SEGMENTS
TABLE 35. ASTRAZENECA PLC.: COMPANY SNAPSHOT
TABLE 36. ASTRAZENECA PLC.: OPERATING SEGMENTS
TABLE 37. BAYER: COMPANY SNAPSHOT
TABLE 38. BAYER: OPERATING SEGMENTS
TABLE 39. ELI LILLY AND COMPANY LIMITED: COMPANY SNAPSHOT
TABLE 40. ELI LILLY AND COMPANY LIMITED: OPERATING SEGMENTS
TABLE 41. ENDO INTERNATIONAL PLC.: COMPANY SNAPSHOT
TABLE 42. ENDO INTERNATIONAL PLC.: OPERATING SEGMENTS
TABLE 43. FERRING: COMPANY SNAPSHOT
TABLE 44. FERRING: OPERATING SEGMENTS
TABLE 45. FINOX AG: COMPANY SNAPSHOT
TABLE 46. FINOX AG: OPERATING SEGMENTS
TABLE 47. IBSA INSTITUT BIOCHIMIQUE SA: COMPANY SNAPSHOT
TABLE 48. IBSA INSTITUT BIOCHIMIQUE SA: OPERATING SEGMENTS
TABLE 49. LABORATOIRES GENVRIER: COMPANY SNAPSHOT
TABLE 50. LABORATOIRES GENVRIER: OPERATING SEGMENTS
TABLE 51. MERCK: COMPANY SNAPSHOT
TABLE 52. MERCK: OPERATING SEGMENTS
TABLE 53. TEVA PHARMACEUTICAL: COMPANY SNAPSHOT
TABLE 54. TEVA PHARMACEUTICAL: OPERATING SEGMENTS

LIST OF FIGURE

FIGURE 1. MALE HYPOGONADISM MARKET SEGMENTATION
FIGURE 2. TOP INVESTMENT POCKETS IN MALE HYPOGONADISM MARKET
FIGURE 3. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, 2013-2015
FIGURE 4. TOP WINNING STRATEGIES: NATURE AND TYPE
FIGURE 5. TOP PLAYER POSITIONING, 2015
FIGURE 6. PERCENTAGE OF MEN WITH LOW LEVELS OF TOTAL AND BIOAVAILABLE TESTOSTERONE
FIGURE 7. DECLINING TESTOSTERONE LEVEL WITH INCREASING AGE
FIGURE 8. PERCENTAGE OF TOTAL POPULATION ABOVE 65 YEARS OF AGE
FIGURE 9. LH MARKET FOR MALE HYPOGONADISM, 2014-2022 ($MILLION)
FIGURE 10. FSH MARKET FOR MALE HYPOGONADISM, 2014-2022 ($MILLION)
FIGURE 11. HCG MARKET FOR MALE HYPOGONADISM, 2014-2022 ($MILLION)
FIGURE 12. GNRH MARKET FOR MALE HYPOGONADISM, 2014-2022 ($MILLION)
FIGURE 13. MALE HYPOGONADISM MARKET SEGMENTATION, BY TYPE
FIGURE 14. CAUSES OF MALE HYPOGONADISM
FIGURE 15. U.S. MALE HYPOGONADISM MARKET, 2014-2022 ($MILLION)
FIGURE 16. CANADA MALE HYPOGONADISM MARKET, 2014-2022 ($MILLION)
FIGURE 17. MEXICO MALE HYPOGONADISM MARKET, 2014-2022 ($MILLION)
FIGURE 18. GERMANY MALE HYPOGONADISM MARKET, 2014-2022 ($MILLION)
FIGURE 19. FRANCE MALE HYPOGONADISM MARKET, 2014-2022 ($MILLION)
FIGURE 20. UK MALE HYPOGONADISM MARKET, 2014-2022 ($MILLION)
FIGURE 21. REST OF EUROPE MALE HYPOGONADISM MARKET, 2014-2022 ($MILLION)
FIGURE 22. CHINA MALE HYPOGONADISM MARKET, 2014-2022 ($MILLION)
FIGURE 23. JAPAN MALE HYPOGONADISM MARKET, 2014-2022 ($MILLION)
FIGURE 24. INDIA MALE HYPOGONADISM MARKET, 2014-2022 ($MILLION)
FIGURE 25. REST OF ASIA-PACIFIC MALE HYPOGONADISM MARKET, 2014-2022 ($MILLION)
FIGURE 26. LATIN AMERICA MALE HYPOGONADISM MARKET, 2014-2022 ($MILLION)
FIGURE 27. MIDDLE EAST MALE HYPOGONADISM MARKET, 2014-2022 ($MILLION)
FIGURE 28. AFRICA MALE HYPOGONADISM MARKET, 2014-2022 ($MILLION)
FIGURE 29. ABBVIE INC.: REVENUE, 2013-2015 ($MILLION)
FIGURE 30. ABBVIE INC.: REVENUE BY SEGMENT, 2015 (%)
FIGURE 31. ABBVIE INC.: REVENUE BY GEOGRAPHY, 2015 (%)
FIGURE 32. ALLERGAN: REVENUE, 2013-2015 ($MILLION)
FIGURE 33. ALLERGAN: REVENUE BY BUSINESS SEGMENT, 2015 (%)
FIGURE 34. ALLERGAN: REVENUE BY GEOGRAPHY, 2015 (%)
FIGURE 35. ASTRAZENECA PLC.: REVENUE, 2013-2015 ($MILLION)
FIGURE 36. ASTRAZENECA PLC.: REVENUE BY GEOGRAPHY, 2015(%)
FIGURE 37. BAYER: REVENUE, 2013-2015 ($MILLION)
FIGURE 38. BAYER: REVENUE BY SEGMENT, 2015 (%)
FIGURE 39. BAYER: REVENUE BY GEOGRAPHY, 2015(%)
FIGURE 40. ELI LILLY AND COMPANY LIMITED: REVENUE, 2013-2015 ($MILLION)
FIGURE 41. ELI LILLY AND COMPANY LIMITED: REVENUE BY SEGMENT, 2015 (%)
FIGURE 42. ELI LILLY AND COMPANY LIMITED: REVENUE BY GEOGRAPHY, 2015 (%)
FIGURE 43. ENDO INTERNATIONAL PLC.: REVENUE, 2013-2015 ($MILLION)
FIGURE 44. ENDO INTERNATIONAL PLC.: REVENUE BY SEGMENT, 2015 (%)
FIGURE 45. ENDO INTERNATIONAL PLC.: REVENUE BY GEOGRAPHY, 2015 (%)
FIGURE 46. MERCK: REVENUE, 2013-2015 ($MILLION)
FIGURE 47. MERCK: REVENUE BY BUSINESS SEGMENT, 2015 (%)
FIGURE 48. MERCK: REVENUE BY GEOGRAPHY, 2015 (%)
FIGURE 49. TEVA PHARMACEUTICAL: REVENUE, 2013-2015 ($MILLION)
FIGURE 50. TEVA PHARMACEUTICAL: REVENUE BY BUSINESS SEGMENT, 2015 (%)
FIGURE 51. TEVA PHARMACEUTICAL: REVENUE BY GEOGRAPHY, 2015 (%)